University of Liverpool


The Physiological Laboratory

This facility is located within the Department of Cellular and Molecular Physiology in the Institute of Translational Medicine is widely recognised as an international centre of excellence for research into cellular and molecular physiology.  The PBRU staff and students work closely with the Physiological Laboratory to investigate calcium signaling in pancreatic acinar cells in pancreatitis, with the aim of finding new drug targets to reduce pancreatic necrosis in acute pancreatitis.

DC_Cells1

DC_Cells2

PSC_mito
 
 
 
 
 
 
 
 
 

 

Chemistry

The PBRU is working with the Department of Chemistry, which is one of the UK’s leading centres for synthetic and medicinal chemistry, to develop new compounds for the possible treatment of pancreatitis

liverpool_biomedical_research_centre

liverpool_biomedical_research_centreliverpool_biomedical_research_centre

 

 

 

 

 
 
 

Wolfson Centre for Personalised Medicines

One of the key researchers of the PBRU holds the NHS Chair of Pharmacogenomics, who leads the Wolfson Centre for Personalised Medicine which is closely linked to the MRC Centre for Drug Safety Science. PBRU staff work with both Centres to determine appropriate strategies for the development, selection and monitoring of drugs and their safe doses for patients with pancreatic disease. 

One of the key researchers of the PBRU holds the NHS Chair of Pharmacogenomics, who leads the Wolfson Centre for Personalised Medicine which is closely linked to the MRC Centre for Drug Safety Science. PBRU staff work with both Centres to determine appropriate strategies for the development, selection and monitoring of drugs and their safe doses for patients with pancreatic disease.  

 

Advanced Genomics Facility (AGF), Centre for Genomic Research, Biological Sciences

The PBRU is collaborating with the Liverpool Microarray Facility, which is based within the AGF for large scale genetic screening in pancreatitis and pancreatic cancer.